RecruitingNot applicableNCT07235826

Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children

Studying Oculocerebral hypopigmentation syndrome, Cross type

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Liaquat University of Medical & Health Sciences
Intervention
Bactoblis® Evol (Streptococcus salivarius Evol12®)(dietary_supplement)
Enrollment
200 target
Eligibility
3-11 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

University of Urbino "Carlo Bo"

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07235826 on ClinicalTrials.gov

Other trials for Oculocerebral hypopigmentation syndrome, Cross type

Additional recruiting or active studies for the same condition.

See all trials for Oculocerebral hypopigmentation syndrome, Cross type

← Back to all trials